Keyphrases
Leukotriene B4 (LTB4)
100%
LTE4
100%
Ulcerative Colitis
100%
Sulfasalazine
57%
Remission Rate
28%
Chronic Inflammatory Bowel Disease
28%
Ulcerative Colitis Patient
28%
Benzoic Acid
14%
Moderate Disease Activity
14%
Receptor Antagonism
14%
Chemotaxis
14%
Fecal Concentration
14%
Serum Concentration
14%
Glucuronide
14%
Clinical Remission
14%
Uncontrolled Study
14%
Placebo
14%
Altered Pharmacokinetics
14%
Neutrophils
14%
Healthy Volunteers
14%
Clinical Symptoms
14%
Open Study
14%
Inhibitory Effect
14%
Moderate to Severe
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Study
100%
Sulfasalazine
100%
Ulcerative Colitis
100%
Remission
75%
Inflammatory Bowel Disease
50%
Placebo
25%
Peptidoleukotriene
25%
Receptor
25%
Pharmacokinetic
25%
Disease Activity
25%
Glucuronide
25%
Normal Human
25%